Skip to content

Why aggregation is key to tackling fake medicines

Gaurav Mohite, global product Manager, Track & Trace at ACG Inspection Systems discusses why aggregation is essential for helping tackle counterfeit medicines.

Why aggregation is key to tackling fake medicines
Published: | 5 min read

Gaurav Mohite, global product Manager, Track & Trace at ACG Inspection Systems discusses why aggregation is essential for helping tackle counterfeit medicines.

Counterfeit

Aggregation is one of the most important topics in pharma manufacturing right now, particularly when it comes to tackling fake medicines and anti-counterfeiting.  It is a crucial part of the ongoing advancement in technology solutions to improve security, visibility and communication in the pharmaceutical supply chain.

Why now? 

Aggregation is building relationships between different products at varying packaging levels. Put in simpler terms, it is also known as establishing parent-child relationships between product packaging levels.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information